Related Experiment Video

Updated: Aug 21, 2026

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Molecular Mechanisms Governing Vascular Function in Heart Failure

Valeria Garrido-Moreno1,2, Anwarul Ferdous1,2, Thomas G Gillette1,2

  • 1Department of Medicine (Cardiology), UT Southwestern Medical Center, Dallas, TX (V.G., A.F, T.G.G., J.A.H).

Arteriosclerosis, Thrombosis, and Vascular Biology
|August 20, 2026
PubMed

Insights

Vascular dysfunction significantly contributes to heart failure development and worsening. Key molecular mechanisms involve endothelial dysfunction, oxidative stress, inflammation, and abnormal blood vessel remodeling.

Area of Science:

  • Cardiovascular Biology
  • Pathophysiology
  • Molecular Medicine

Background:

  • Heart failure is a major global health burden.
  • Vascular dysfunction is increasingly recognized as a critical factor in heart failure.
  • The heart and blood vessels have a complex, interdependent relationship.

Purpose of the Study:

  • To summarize molecular mechanisms linking vascular dysfunction to heart failure.
  • To highlight the role of endothelial cells and vascular remodeling.
  • To emphasize key signaling pathways involved in cardiovascular homeostasis.

Main Methods:

  • Literature review and synthesis of current research.
  • Focus on molecular and cellular mechanisms.
  • Emphasis on endothelial signaling, oxidative stress, inflammation, and angiogenesis.

Main Results:

  • Dysregulation of endothelium-derived mediators (e.g., NO, endothelin-1) impairs heart function.
  • Vascular oxidative stress and inflammation contribute to heart failure progression.
  • Abnormal vascular remodeling, including reduced angiogenesis, exacerbates the condition.

Conclusions:

  • Vascular dysfunction is a central driver of heart failure.
  • Targeting vascular mechanisms offers potential therapeutic strategies.
  • Understanding these molecular links is crucial for managing heart failure.

Keywords:
coronary diseaseendothelial cellsheart failureinflammationperfusion

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...